Vitrolife's earnings have been declining at an average annual rate of -49.2%, while the Biotechs industry saw earnings growing at 33.8% annually. Revenues have been growing at an average rate of 15.2% per year.
Key information
-49.15%
Earnings growth rate
-49.64%
EPS growth rate
Biotechs Industry Growth
17.04%
Revenue growth rate
15.19%
Return on equity
-62.07%
Net Margin
-147.17%
Next Earnings Update
16 Jul 2026
Recent past performance updates
Recent updates
Revenue & Expenses Breakdown
How Vitrolife makes and spends money. Based on latest reported earnings, on an LTM basis.
Earnings and Revenue History
OTCPK:VTRL.Y Revenue, expenses and earnings (SEK Millions)
Date
Revenue
Earnings
G+A Expenses
R&D Expenses
31 Mar 26
3,405
-5,011
1,331
124
31 Dec 25
3,440
-5,012
1,318
118
30 Sep 25
3,507
440
1,284
110
30 Jun 25
3,541
455
1,262
113
31 Mar 25
3,610
498
1,243
110
31 Dec 24
3,609
513
1,232
117
30 Sep 24
3,555
-3,805
1,181
117
30 Jun 24
3,535
-3,799
1,150
118
31 Mar 24
3,499
-3,836
1,118
126
31 Dec 23
3,512
-3,851
1,117
127
30 Sep 23
3,462
402
1,092
122
30 Jun 23
3,412
388
1,076
124
31 Mar 23
3,336
412
1,048
133
31 Dec 22
3,234
394
1,002
143
30 Sep 22
2,893
353
961
157
30 Jun 22
2,501
349
811
151
31 Mar 22
2,054
305
656
133
31 Dec 21
1,681
341
503
114
30 Sep 21
1,549
415
353
103
30 Jun 21
1,464
399
333
94
31 Mar 21
1,291
325
308
91
31 Dec 20
1,246
287
311
92
30 Sep 20
1,273
276
324
97
30 Jun 20
1,331
294
342
102
31 Mar 20
1,502
377
365
105
31 Dec 19
1,480
383
351
100
30 Sep 19
1,391
371
342
88
30 Jun 19
1,297
339
318
80
31 Mar 19
1,199
324
293
74
31 Dec 18
1,151
310
284
72
30 Sep 18
1,102
294
278
70
30 Jun 18
1,064
284
276
70
31 Mar 18
1,066
276
276
69
31 Dec 17
1,046
264
270
69
30 Sep 17
1,026
255
266
71
30 Jun 17
991
234
262
70
31 Mar 17
913
211
254
68
31 Dec 16
856
190
250
62
30 Sep 16
804
188
235
55
30 Jun 16
771
196
231
55
31 Mar 16
747
186
223
53
31 Dec 15
722
183
220
56
30 Sep 15
660
154
213
56
30 Jun 15
609
137
195
48
Quality Earnings: VTRL.Y is currently unprofitable.
Growing Profit Margin: VTRL.Y is currently unprofitable.
Free Cash Flow vs Earnings Analysis
Past Earnings Growth Analysis
Earnings Trend: VTRL.Y is unprofitable, and losses have increased over the past 5 years at a rate of 49.2% per year.
Accelerating Growth: Unable to compare VTRL.Y's earnings growth over the past year to its 5-year average as it is currently unprofitable
Earnings vs Industry: VTRL.Y is unprofitable, making it difficult to compare its past year earnings growth to the Biotechs industry (43%).
Return on Equity
High ROE: VTRL.Y has a negative Return on Equity (-62.07%), as it is currently unprofitable.
Return on Assets
Return on Capital Employed
Discover strong past performing companies
7D
1Y
7D
1Y
7D
1Y
Company Analysis and Financial Data Status
Data
Last Updated (UTC time)
Company Analysis
2026/05/23 22:52
End of Day Share Price
2026/05/19 00:00
Earnings
2026/03/31
Annual Earnings
2025/12/31
Data Sources
The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.
* Example for US securities, for non-US equivalent regulatory forms and sources are used.
Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more.
Analysis Model and Snowflake
Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.
Learn about the world class team who designed and built the Simply Wall St analysis model.
Industry and Sector Metrics
Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on Github.
Analyst Sources
Vitrolife AB (publ) is covered by 12 analysts. 5 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.